Literature DB >> 10497624

Diabetes as a risk factor for myocardial infarction: population and gender perspectives.

V Lundberg1, B Stegmayr, K Asplund, M Eliasson, F Huhtasaari.   

Abstract

OBJECTIVES: To investigate diabetes as a risk factor for acute myocardial infarction (AMI) from a population perspective in a region with high cardiovascular disease (CVD) risk.
DESIGN: Population screenings for diabetes and a population-based AMI register.
SETTING: Northern Sweden MONICA area.
SUBJECTS: Representative sample (Norrbotten and Västerbotten counties) of 2432 men and women 35-64 years was investigated 1990 and 1994. All patients with AMI aged 35-64 years were included, in total 3031 between 1989 and 1993.
RESULTS: The prevalence of diabetes was 5% in men and 4.4% in women. The relative risk (RR) in diabetic men was 2.9; 95% confidence interval (CI) 2.6-3.4, and in diabetic women, RR 5.0; CI 3.9-6.3. The risk for re-infarction was about twice as large in patients with diabetes as in patients without diabetes. In both sexes the overall 28 day case fatality (CF) was significantly higher in diabetic compared to non-diabetic subjects. When compared to the non-diabetic population, the overall mortality from AMI in the diabetic population was 4 times higher among men and 7 times higher among women. The population attributable risk (PAR), a crude estimate of all AMIs ascribed to diabetes, was 11% in men and 17% in women.
CONCLUSIONS: Diabetes increases the risk for AMI attack rate, incidence, case-fatality, recurrence and mortality and is an important contributor to all AMIs in middle-aged people.

Entities:  

Mesh:

Year:  1997        PMID: 10497624     DOI: 10.1111/j.1365-2796.1997.tb00006.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  30 in total

Review 1.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Cardiovascular events in users of sildenafil. Paper does not provide any reassurance.

Authors:  N Dunn
Journal:  BMJ       Date:  2001-07-07

Review 3.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

Review 4.  Uric acid as a factor in the metabolic syndrome.

Authors:  Rodolfo Leão Borges; Artur Beltrame Ribeiro; Maria Teresa Zanella; Marcelo Costa Batista
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

5.  Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.

Authors:  C Andersson; L van Gaal; I D Caterson; P Weeke; W P T James; W Coutinho; W Couthino; N Finer; A M Sharma; A P Maggioni; C Torp-Pedersen
Journal:  Diabetologia       Date:  2012-05-26       Impact factor: 10.122

Review 6.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

Review 7.  Should all diabetic patients receive statins?

Authors:  Paul J Garcia; Craig W Spellman
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

8.  Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.

Authors:  Trine B Opstad; Alf Age Pettersen; Thomas Weiss; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2010-05-05

9.  Gut metagenome in European women with normal, impaired and diabetic glucose control.

Authors:  Fredrik H Karlsson; Valentina Tremaroli; Intawat Nookaew; Göran Bergström; Carl Johan Behre; Björn Fagerberg; Jens Nielsen; Fredrik Bäckhed
Journal:  Nature       Date:  2013-05-29       Impact factor: 49.962

10.  The prevalence of metabolic syndrome among US women of childbearing age.

Authors:  Rosemarie G Ramos; Kenneth Olden
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.